Interleukin-1 genetic association with periodontitis in clinical practice

Journal of Periodontology

Volumn 71, Issue 2, 2000, Pages 156-163

  McDevitt, Michael J ^d   Wang, Hwa Ying ^a   Knobelman, Carol ^a   Newman, Michael G ^b   Di Giovine, Francesco S ^c   Timms, Janice ^c   Duff, Gordon W ^c   Kornman, Kenneth S ^a  

^a Interleukin Genetics Inc   (United States)

^b UCLA SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d NONE

Author keywords

Genotype; Interleukin 1; Periodontitis epidemiology; Risk factors; Smoking

Indexed keywords

INTERLEUKIN 1;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 2; ETHNOLOGY; EUROPE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY; PERIODONTITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SMOKING; STATISTICAL MODEL; UNITED STATES;

ADULT; AGE FACTORS; ALVEOLAR BONE LOSS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 2; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIODONTITIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SMOKING; UNITED STATES;

EID: 0034134094     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.71.2.156     Document Type: Article

References (41)

1. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
2. Grossi SG, Zambon JJ, Ho A, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
3. King RA, Rotter JI, Motulsky AG. The approach to genetic bases of common diseases. In: King RA, Rotter JI, Motulsky AG, eds. Oxford Monographs on Medical Genetics. New York: Oxford University Press. 1992:3-18.
4. Papapapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996;1:1-36.
5. Michalowicz BS, Aeppli D, Kuba RK, et al. A twin study of genetic variation in proportional radiographic alveolar bone height. J Dent Res 1991;70:1431-1435.
6. Michalowicz BS, Aeppli D, Virag JG, et al. Periodontal findings in adult twins. J Periodontol 1991;62:293-299.
7. Hassell TM, Harris EL. Genetic influences in caries and periodontal disease. Crit Rev Oral Biol Med 1995;6:319-342.
8. Hart T, Kornman KS. Genetic factors in the pathogenesis of periodontitis. Periodontol 2000 1997;14:202-215
9. Kornman KS, Crane A, Wang H-Y, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
10. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992;22:396-402
11. Gore EA, Sanders JJ, Pandey JP, Palesch Y, Galbraith GMP. Interleukin-1β+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol 1998;25:781-785.
12. McGuire MK, Nunn ME. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and PST genotype in accurately predicting prognosis and tooth survival. J Periodontol 1999;70:49-57.
13. Hausmann E, Allen K, Carpio L, Christersson LA, Clerehugh V. Computerized methodology for detection of alveolar crestal bone loss from serial intraoral radiographs. J Periodontol 1992;63:657-662.
14. Hausmann E, Allen K. Reproducibility of bone height measurements made on serial radiographs. J Periodontol 1997;68:839-841.
15. di Giovine FS, Cork MJ, Crane A, Mee JB, Duff GW. Novel genetic association of an IL-1B gene variation a +3953 with IL-1β protein production and psoriasis [abstract]. Cytokine 1995;7:606.
16. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: A risk factor for severity of adult periodontitis. Ann Periodontol 1998;3:327-338
17. Tonetti M. Cigarette smoking and periodontal diseases: etiology and management of disease. Ann Periodontol 1998;3:88-101.
18. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996;67(Suppl.): 1094-1102.
19. Grossi S, Genco R, Machtei E, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995;66:23-29.
20. Martinez-Canut P, Lorca A, Magan R. Smoking and periodontal disease severity. J Clin Periodontol 1995;22:743-749.
21. Bergstrom J, Preber H. Tobacco use as a risk factor. J Periodontol 1994;65(Suppl.):545-550.
22. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996;67:675-81.
23. Ah MKB, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL. The effect of smoking on the response to periodontal therapy. J Clin Periodontol 1994;21:91-97.
24. Tonetti MS, Pini Prato G, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-34.
25. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
26. Wilson TG, Kornman KS. Treating chronic periodontitis with early or moderate attachment loss. In: Wilson TG, Kornman KS, eds. Fundamentals of Periodontics. Chicago: Quintessence: 1996:349-355.
27. Hou LT, Liu C-M, Rossomando EF. Crevicular interleukin-1β in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995;22:162-167.
28. Feldner BD, Reinhardt RA, Garbin CP, Seymour, GJ, Casey JH. Histological evaluation of interleukin-1β and collagen in gingival tissue from untreated adult periodontitis. J Periodont Res 1994;29:54-61.
29. Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. J Periodont Res 1993;28:543-546.
30. Wilton JM, Bamption JL, Griffiths GS, et al. Interleukin-1 beta (IL-1β) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontitis. A cross sectional study. J Clin Periodontol 1992; 19:53-57.
31. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin-1β in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
32. Masada MP, Persson R, Kenney JS, et al. Measurement of interleukin-1α and -1β in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990;26:156-163.
33. Zachariasen R. Oral manifestations of menopause. Compendium Cont Educ Dent 1993;14:1584-1567.
34. Genco R. Assessment of risk of periodontal disease. Compendium Cont Educ Dent 1994;Supp 18:s678-s683.
35. Engebretson SP, Lamster IA, Herrera-Abrev M, et al. The influence of interleukin gene polymorphism on expression of interleukin-1β and tumor necrosis factor-α in periodontal tissue and gingival crevicular fluid. J Periodontol 1999;70:567-573.
36. Agarwal S, Chandra CS, Piesco NP, Langkamp HH, Bowen L, Baran C. Regulation of periodontal ligament cell function by IL-1 beta. Infect Immun 1998;66:932-937.
37. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997;14:112-143.
38. Graves DT, Delima A, Assuma R, Amar S, Oates T, Cochran D. IL-1 and TNF antagonist inhibit periodontal inflammation. J Dent Res 1998;77(Spec. Issue):181 (Abstr. 605).
39. Consensus Report. Periodontal diseases: Pathogenesis and microbial factors. Ann Periodontol 1996;1:926-933.
40. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med 1981;304:65-70.
41. Merin RL. Supportive periodontal treatment. In: Carranza F, Newman MG, Clinical Periodontology, 8th ed. Philadelphia: WB Saunders. 1996:743-753.